| scholarly article | Q13442814 |
| P50 | author | Harvey M. Friedman | Q89912954 |
| Helen M. Lazear | Q37367303 | ||
| P2093 | author name string | John M Lubinski | |
| Sita Awasthi | |||
| Fushan Wang | |||
| P2860 | cites work | Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging | Q21092776 |
| An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI. | Q39605520 | ||
| Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. | Q39642352 | ||
| Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs | Q39686594 | ||
| Herpes simplex virus type 1 glycoprotein E mediates retrograde spread from epithelial cells to neurites | Q39874187 | ||
| Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells | Q39882095 | ||
| Genetics of natural resistance to herpesvirus infections in mice | Q39958787 | ||
| Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. | Q40040178 | ||
| Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI | Q40065898 | ||
| Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species | Q40124901 | ||
| The role of NK1.1+ cells in the protection against MHC class I+ HPV16-associated tumours. | Q40458745 | ||
| The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains | Q41105435 | ||
| Mapping regions of herpes simplex virus type 1 glycoprotein I required for formation of the viral Fc receptor for monomeric IgG. | Q41143799 | ||
| Characterization of regions of herpes simplex virus type 1 glycoprotein E involved in binding the Fc domain of monomeric IgG and in forming a complex with glycoprotein I. | Q41389075 | ||
| Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. | Q41611323 | ||
| Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells | Q41900199 | ||
| Fcγ Receptor-like Activity of Hepatitis C Virus Core Protein | Q42981184 | ||
| Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis | Q43530697 | ||
| Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. | Q44062957 | ||
| ADSORPTION OF SENSITIZED SHEEP ERYTHROCYTES TO HELA CELLS INFECTED WITH HERPES SIMPLEX VIRUS. | Q44582827 | ||
| Culturing primary and transformed neuronal cells for studying pseudorabies virus infection | Q45558330 | ||
| Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection | Q45733086 | ||
| Virus Infection of Endothelial Cells | Q45802359 | ||
| Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins | Q45841413 | ||
| Spontaneous ocular shedding of HSV-1 in latently infected rabbits | Q70081113 | ||
| Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells | Q78680362 | ||
| Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E | Q24646778 | ||
| Genetic Markers of IgG Influence the Outcome of Infection with Hepatitis C Virus | Q27488362 | ||
| Immunoglobulin concentrations in human tears in ocular diseases | Q33651328 | ||
| Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin | Q33720617 | ||
| In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. | Q33784845 | ||
| Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo | Q33784923 | ||
| The role of complement in B cell activation and tolerance. | Q33799789 | ||
| Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease | Q33808376 | ||
| Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein | Q33849391 | ||
| Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection | Q33919647 | ||
| Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2 | Q33919700 | ||
| Neuron-to-cell spread of pseudorabies virus in a compartmented neuronal culture system | Q33930401 | ||
| The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors | Q33987514 | ||
| Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins | Q34092761 | ||
| Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1 | Q34185445 | ||
| Herpes simplex virus type 1 evades the effects of antibody and complement in vivo | Q34345831 | ||
| Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus | Q35851060 | ||
| The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | Q36228791 | ||
| A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. | Q36540912 | ||
| Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells | Q36626714 | ||
| Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes | Q36807128 | ||
| Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity | Q36829124 | ||
| A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. | Q36831366 | ||
| A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine | Q36845870 | ||
| Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. | Q36866263 | ||
| Role of antibody in primary and recurrent herpes simplex virus infection | Q36899596 | ||
| Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors | Q36936682 | ||
| Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein | Q36936703 | ||
| Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor | Q36955074 | ||
| Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. | Q37333821 | ||
| Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein | Q37601627 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 3239-3249 | |
| P577 | publication date | 2011-01-12 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo | |
| P478 | volume | 85 |
| Q90520696 | A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection |
| Q34549656 | An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. |
| Q90107838 | Antibody-mediated complement activation in pathology and protection |
| Q34057952 | Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes |
| Q38257496 | CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity |
| Q56880960 | CNS Infections |
| Q27320966 | Characterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68 |
| Q33804431 | Complement Evasion Strategies of Viruses: An Overview |
| Q35414669 | Evasion of early antiviral responses by herpes simplex viruses |
| Q35804208 | HSV-1 Glycoproteins Are Delivered to Virus Assembly Sites Through Dynamin-Dependent Endocytosis |
| Q64078553 | Herpes Simplex Virus Evasion of Early Host Antiviral Responses |
| Q55397851 | Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases? |
| Q33618817 | Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III |
| Q38116993 | Immunity to bovine herpesvirus 1: II. Adaptive immunity and vaccinology |
| Q35275146 | Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa |
| Q39224323 | Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion. |
| Q38241377 | Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. |
| Q35192694 | Interaction and interdependent packaging of tegument protein UL11 and glycoprotein e of herpes simplex virus |
| Q38692329 | Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease. |
| Q27347896 | Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa |
| Q38824720 | Novel Evasion Mechanisms of the Classical Complement Pathway. |
| Q60044040 | Oncolytic herpes simplex virus and immunotherapy |
| Q38920459 | Oncolytic herpes simplex virus interactions with the host immune system |
| Q21284969 | Systemic delivery of oncolytic viruses: hopes and hurdles |
| Q38650844 | The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. |
| Q90290839 | The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity |
| Q27330259 | The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface |
| Q42256835 | Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection |
| Q90437526 | Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity |
| Q55406946 | Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs. |
| Q91766368 | Vaccines to prevent genital herpes |
Search more.